V9 Anti-Human CTLA4 (Ipilimumab)
Product Specifications
Expression System
CHO
Reactivity
Human
Target
CTLA-4
Purification
IEC
Endotoxin
<1EU/mg Determined by LAL gel clotting assay
Purity
>95% Determined by SDS-PAGE
Buffer
ABDB-1002 or PBS, pH 7.4, Contains no stabilizers or preservatives.
Storage Conditions
The product need to be stored at the original stock concentration at 4°C.Avoid freeze / thaw cycle.
Formulation
PBS, pH 7.4, Contains no stabilizers or preservatives
Sterility
0.2 μM filtered
Isotype
Human IgG1 (K214R/E356D/M358L) -Kappa
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6443433-01 0.1 mL
WNK1 (With-No-Lysine Kinase 1, Kinase deficient protein, KDP, PSK, p65, HSN2, HSAN2, PRKWNK1) (MaxLight 650)
Sign In for Pricing
View Details MBS6443433-02 5x 0.1 mL
WNK1 (With-No-Lysine Kinase 1, Kinase deficient protein, KDP, PSK, p65, HSN2, HSAN2, PRKWNK1) (MaxLight 650)
Sign In for Pricing
View Details 
K2511102 1.0 µg DNA
TRNAP11 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
S6504-40G 50 µg
Src, phosphorylated (Tyr529) (Proto-oncogene Tyrosine-protein Kinase Src, Proto-oncogene c-Src, pp60c-src, p60-Src, SRC1) discontinued
Sign In for Pricing
View Details